(Lack of) FDA device monitoring draws new scrutiny

The FDA is facing new criticism over the lack of a dedicated monitoring system to track problems with artificial hips, pacemakers or other devices. The journalism outfit ProPublica reports on the issue in an article that highlights the shortfall. Each prescription drug has a unique code the government can use to track reports of problems, whereas medical devices do not, the story notes. For devices, the FDA depends on voluntary reports from providers, patients and devicemakers, and only after these reports come in can regulators require further action. To the FDA's credit, and as the article notes, the agency posts adverse event reports online once it receives them. Furthermore, work is under way to use electronic health records data and medical claims to track devices as well as drugs and vaccines (The Sentinel Initiative). Congress has mandated the establishment of a post-market surveillance system to track medical device safety once products are used commercially. But that process hasn't been established yet, 5 years after Congress stepped in. Story

Suggested Articles

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.